<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e>) is a <z:e sem="disease" ids="C0410787" disease_type="Disease or Syndrome" abbrv="">heritable connective tissue disorder</z:e> manifested by defects in the skeletal, ocular, and cardiovascular systems </plain></SENT>
<SENT sid="1" pm="."><plain>It is inherited as an <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> trait, with an incidence of nearly one per 10,000 population without gender or ethnic predilection </plain></SENT>
<SENT sid="2" pm="."><plain>About 30% of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> cases are <z:hpo ids='HP_0003745'>sporadic</z:hpo>, representing new dominant mutations </plain></SENT>
<SENT sid="3" pm="."><plain>Although diagnostic criteria may be met, intra- and inter-familial variability in syndromic expression can be quite marked </plain></SENT>
<SENT sid="4" pm="."><plain>Life expectancy is significantly reduced, and more than 85% of patients die of cardiovascular complications </plain></SENT>
<SENT sid="5" pm="."><plain>Elastin-associated microfibrils are classically identified by a 10-12 nm cross-sectional diameter and close association with amorphous elastin </plain></SENT>
<SENT sid="6" pm="."><plain>Characteristically, these microfibrils are seen as a fringe surrounding elastin cores </plain></SENT>
<SENT sid="7" pm="."><plain>Despite their name, these fibrils are frequently localized in tissues not associated with elastin </plain></SENT>
<SENT sid="8" pm="."><plain>One of the major and best characterized microfibrillar proteins is the <z:chebi fb="2" ids="17089">glycoprotein</z:chebi>, fibrillin </plain></SENT>
<SENT sid="9" pm="."><plain>Fibrillin is rich in <z:chebi fb="0" ids="32460">cysteine residues</z:chebi> and thus, extensively intrachain <z:chebi fb="0" ids="48343">disulfide</z:chebi> bonded </plain></SENT>
<SENT sid="10" pm="."><plain>Defects in fibrillin are now known to cause the variable and pleiotropic manifestations of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>Immunofluorescence studies of skin sections and dermal fibroblast cultures were the first to show this association </plain></SENT>
<SENT sid="12" pm="."><plain>The cloning and sequencing of the entire fibrillin coding region has enabled the identification of the myriad of mutations that cause <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> </plain></SENT>
<SENT sid="13" pm="."><plain>Identification of the molecular lesions covering the gamut of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> clinical variability should allow the construction of genotype/phenotype correlations </plain></SENT>
<SENT sid="14" pm="."><plain>It is hoped that once available, they may become of prognostic value in the clinical management of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> </plain></SENT>
</text></document>